BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38401774)

  • 1. Antiviral activity of immunosuppressors alone and in combination against human adenovirus and cytomegalovirus.
    Carretero-Ledesma M; Aguilar-Guisado M; Berastegui-Cabrera J; Balsera-Manzanero M; Pachón J; Cordero E; Sánchez-Céspedes J
    Int J Antimicrob Agents; 2024 May; 63(5):107116. PubMed ID: 38401774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro co-infection by cytomegalovirus improves the antiviral activity of ganciclovir against human adenovirus.
    Aguilar-Guisado M; Marrugal-Lorenzo JA; Berastegui-Cabrera J; Merino L; Pachón J; Sánchez-Céspedes J
    Int J Antimicrob Agents; 2020 Aug; 56(2):106046. PubMed ID: 32540429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication.
    Favi E; Signorini L; Villani S; Dolci M; Ticozzi R; Basile G; Ferrante P; Ferraresso M; Delbue S
    Transplant Proc; 2022 Sep; 54(7):2035-2041. PubMed ID: 35659782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
    McCrea JB; Macha S; Adedoyin A; Marshall W; Menzel K; Cho CR; Liu F; Zhao T; Levine V; Kraft WK; Yoon E; Panebianco D; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2019 Oct; 59(10):1331-1339. PubMed ID: 30990905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of sirolimus in patients with recurrent cytomegalovirus infection after kidney transplantation: A retrospective case series analysis.
    Shendi AM; Hung RKY; Caplin B; Griffiths P; Harber M
    Saudi J Kidney Dis Transpl; 2019; 30(3):606-614. PubMed ID: 31249224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study.
    Viganò M; Dengler T; Mattei MF; Poncelet A; Vanhaecke J; Vermes E; Kleinloog R; Li Y; Gezahegen Y; Delgado JF;
    Transpl Infect Dis; 2010 Feb; 12(1):23-30. PubMed ID: 19744284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
    Kyles AE; Gregory CR; Craigmill AL
    Am J Vet Res; 2000 Aug; 61(8):906-9. PubMed ID: 10951980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
    Baldanti F; Gerna G
    J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs.
    Mercorelli B; Celegato M; Luganini A; Gribaudo G; Lepesheva GI; Loregian A
    Antiviral Res; 2021 May; 189():105062. PubMed ID: 33722615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad and Efficient Activation of Memory CD4
    Höttler A; März L; Lübke M; Rammensee HG; Stevanović S
    Front Immunol; 2021; 12():700438. PubMed ID: 34322126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures.
    Oliveira VD; Zankl H; Rath T
    Exp Clin Transplant; 2004 Dec; 2(2):273-9. PubMed ID: 15859941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
    Drouot E; Piret J; Boivin G
    Antivir Ther; 2016; 21(6):535-539. PubMed ID: 26844400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of prophylactic antiviral agents and statin administration on graft longevity in kidney allograft recipients.
    Rahal EA; Chakhtoura M; Dargham RA; Khauli RB; Medawar W; Abdelnoor AM
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):763-7. PubMed ID: 22292901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
    Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.
    Henry SD; Metselaar HJ; Lonsdale RC; Kok A; Haagmans BL; Tilanus HW; van der Laan LJ
    Gastroenterology; 2006 Nov; 131(5):1452-62. PubMed ID: 17101321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
    Rodríguez-Perálvarez M; Guerrero-Misas M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011639. PubMed ID: 28362060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients.
    Havenith SH; Yong SL; van Donselaar-van der Pant KA; van Lier RA; ten Berge IJ; Bemelman FJ
    Transplantation; 2013 Jan; 95(1):184-91. PubMed ID: 23222818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus.
    Wang SS; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Ko WJ; Tsao CI; Sun CD
    Transplant Proc; 2008 Oct; 40(8):2607-8. PubMed ID: 18929814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
    Hussein ITM; Brooks J; Bowlin TL
    Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.